3 environmental issues disproportionately affecting Hispanic patients
Special factors influencing the health of the Hispanic population stepped into the spotlight during a panel discussion last week. Learn what health care researchers are discovering about environmental factors that impact the health of this underserved patient population.
Researchers and physicians at the event hosted by the AMA Minority Affairs Section and the National Hispanic Medical Association discussed how multiple factors—ranging from a lack of Hispanic physicians in medicine to lurking environmental contaminants—shape Hispanic health. Some of the top issues they discussed included:
The impact of environ...
Source: AMA Wire - October 13, 2015 Category: Journals (General) Authors: amamod Source Type: news
Medtech approvals: FDA releases June 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in June 2015:
Summary of PMA Originals & Supplements Approved
Originals: 5
Supplements: 80
Summary of PMA Originals Under Review
Total Under Review: 53
Total Active: 22
Total On Hold: 31
Summary of PMA Supplements Under Review
Total Under Review: 575
Total Active: 418
Total On Hold: 157
Summary of All PMA Submissions
Originals: 4
Supplements: 72
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 80
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 115.2
FDA Time: 97.1 ...
Source: Mass Device - August 20, 2015 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news
Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that the U.S. Centers for Disease Control and
Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP)
voted to include GARDASIL®9 (Human Papillomavirus 9-valent
Vaccine, Recombinant) in the recommendations for use of HPV vaccines.
GARDASIL 9 has been added to the routine recommendations for vaccination
of 11- and 12- year-old females and males. The vacci...
Source: Merck.com - Corporate News - February 26, 2015 Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News Source Type: news
What You Should Know Before You Schedule Your Next Doctor Appointment
Before we were able to Google our every itch and twinge and ache, we had very different relationships with our doctors.
“In the early years of my career, information was something the doctor had and the patient didn’t,” Dr. Michael L. LeFevre, a professor and physician at the University of Missouri, tells The Huffington Post. Today, he says, patients bring their information to him for his input. “They want my opinion about how good the information is and what it means and how to interpret it for them in their lives.”
Of course, the Internet is rife with misinformation, and sometimes a well-meaning patient will ...
Source: Healthy Living - The Huffington Post - February 10, 2015 Category: Consumer Health News Source Type: news
Why Some Vaccines Require More Than One Dose
Despite being declared beaten in 2000, measles is back, due largely to declining vaccination rates in parts of the United States.
"We should not be in this boat," Dr. Pritish Tosh, an infectious diseases physician and researcher at the Mayo Clinic, told The Huffington Post. "This is a completely preventable disease."
That's because of the measles, mumps and rubella vaccine, which Tosh called "phenomenal" in its ability to protect large percentages of the general population.
The vaccine is one of several different vaccines, however, that are given in multiple doses. Children receive the first dose of the MMR vaccine betw...
Source: Science - The Huffington Post - February 7, 2015 Category: Science Source Type: news
Interim Guidance Released on Primary High-Risk HPV Testing for Cervical Cancer (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
High-risk human papillomavirus (hrHPV) testing can be used as an alternative to cytology or co-testing for primary cervical cancer screening, according to new interim guidance from a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 12, 2015 Category: Primary Care Source Type: news
Docs suggest HPV screening first for cervical cancer
(Reuters Health) - Two medical organizations have recommended testing for the human papillomavirus (HPV) to screen women for cervical cancer before using a Papanicolaou – or Pap – smear for screening. (Source: Reuters: Health)
Source: Reuters: Health - January 8, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Screening HPV infection alone more accurate than Pap test in detection of cervical cancer
(Elsevier) Screening for human papillomavirus (HPV) infection alone gives more accurate results than Pap testing for cervical cancer, say the authors of two papers to published today in the journal Gynecologic Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2015 Category: Global & Universal Source Type: news
HPV urine test could screen for cervical cancer
Conclusion
This systematic review and meta-analysis indicates that urine tests for detecting HPV DNA might be feasible for screening women for cervical cancer based on an evidence base of 14 diverse studies involving 1,443 women.
While it is feasible this type of test might be useful for screening, there were many limitations in the evidence base reviewed. This means its effectiveness as a screening tool is still up for debate and is unproven.
Issues include:
the large variation between individual studies for participant characteristics
the large variation in estimates of test sensitivity and specificity between...
Source: NHS News Feed - September 17, 2014 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news
Urine HPV Testing an Acceptable Alternative to Cervical HPV Testing? (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Urine detection of human papillomavirus DNA could be an alternative to cervical DNA testing, according to a BMJ meta-analysis.Researchers examined … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 17, 2014 Category: Primary Care Source Type: news
Blood and saliva tests help predict return of HPV-linked oral cancers
Physicians have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients. The tests screen for DNA fragments of the human papillomavirus (HPV) shed from cancer cells lingering in the mouth or other parts of the body. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 1, 2014 Category: Science Source Type: news
Blood and saliva tests help predict return of HPV-linked oral cancers
(Johns Hopkins Medicine) Physicians at Johns Hopkins have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients. The tests screen for DNA fragments of the human papillomavirus shed from cancer cells lingering in the mouth or other parts of the body. A description of the development is published in the July 31 issue of JAMA Otolaryngology -- Head & Neck Surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 31, 2014 Category: Cancer & Oncology Source Type: news
Incomplete HPV vaccination may offer some protection
(Boston University Medical Center) Minority women who received the Human Papillomavirus Vaccination even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal Sexually Transmitted Diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2014 Category: Global & Universal Source Type: news
HPV test better than Pap for assessing cervical cancer risk: study
NEW YORK (Reuters Health) - Testing for human papillomavirus (HPV) may be the best way to know whether a woman is at risk of developing cervical cancer in the near future, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - July 18, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Ask Well: Do Monogamous Women Still Need a Pap Smear?
Most cases of cervical cancer are linked with the sexually transmitted HPV virus. So why are monogamous women who test negative for HPV still given pap smears? (Source: NYT)
Source: NYT - June 9, 2014 Category: Nutrition Authors: By TARA PARKER-POPE Tags: Ask Well Body medicine and health Featured Tests (Medical) Human Papillomavirus (HPV) Source Type: news
